Kaposi Sarcoma — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Kaposi sarcoma; reduce immunosuppression and consider switch from Ciclosporin to Sirolimus
HHV-8 (KSHV) positive spindle cell lesions with slit-like vascular spaces in a transplant recipient are diagnostic of Kaposi sarcoma (KS). The first management step is reduction of immunosuppression. Switching from calcineurin inhibitors (Ciclosporin/Tacrolimus) to mTOR inhibitors (Sirolimus/Everolimus) has anti-angiogenic and anti-tumour properties beneficial in transplant-associated KS. Chemotherapy (liposomal Doxorubicin) is reserved for extensive or visceral disease.
Reference: NICE 2023 – Post-transplant malignancy; BTS 2024 – Post-transplant guidelines